Investigation of the Reproducibility of Portable Optical Coherence Tomography in Diabetic Macular Edema

<b>Background:</b> Diabetic macular edema (DME) causes vision impairment and significant vision loss. Portable optical coherence tomography (OCT) has the potential to enhance the accessibility and frequency of DME screening, facilitating early diagnosis and continuous monitoring. This st...

Full description

Saved in:
Bibliographic Details
Main Authors: Yoshiaki Chiku (Author), Takao Hirano (Author), Marie Nakamura (Author), Yoshiaki Takahashi (Author), Hideki Miyasaka (Author), Ken Hoshiyama (Author), Toshinori Murata (Author)
Format: Book
Published: MDPI AG, 2024-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_140489d7176e4c20a9afd70d7ee6db57
042 |a dc 
100 1 0 |a Yoshiaki Chiku  |e author 
700 1 0 |a Takao Hirano  |e author 
700 1 0 |a Marie Nakamura  |e author 
700 1 0 |a Yoshiaki Takahashi  |e author 
700 1 0 |a Hideki Miyasaka  |e author 
700 1 0 |a Ken Hoshiyama  |e author 
700 1 0 |a Toshinori Murata  |e author 
245 0 0 |a Investigation of the Reproducibility of Portable Optical Coherence Tomography in Diabetic Macular Edema 
260 |b MDPI AG,   |c 2024-10-01T00:00:00Z. 
500 |a 10.3390/ph17101357 
500 |a 1424-8247 
520 |a <b>Background:</b> Diabetic macular edema (DME) causes vision impairment and significant vision loss. Portable optical coherence tomography (OCT) has the potential to enhance the accessibility and frequency of DME screening, facilitating early diagnosis and continuous monitoring. This study aimed to evaluate the reliability of a portable OCT device (ACT100) in assessing DME compared with a traditional stationary OCT device (Cirrus 5000 HD-OCT plus). <b>Methods:</b> This prospective clinical investigation included 40 eyes of 33 patients with DME. Participants with significant refractive errors (myopia > −6.0 diopters or hyperopia > +3.0 diopters), vitreous hemorrhage, tractional retinal detachment, or other ocular diseases affecting imaging were excluded. Spectral-domain OCT was performed by a single examiner using both devices to capture macular volume scans under mydriasis. Central macular thickness (CMT) was evaluated using the analysis software for each device: Cirrus used version 6.0.4, and ACT100 used version V20. We analyzed inter-evaluator and inter-instrument agreements for qualitative assessments of the intraretinal fluid (IRF), subretinal fluid (SRF), and epiretinal membrane (ERM) using Cohen's kappa coefficient, whereas quantitative CMT assessments were correlated using Spearman's correlation coefficient. <b>Results:</b> Substantial inter-evaluator agreement for IRF/SRF (κ = 0.801) and ERM (κ = 0.688) with ACT100 and inter-instrument agreement (κ = 0.756 for IRF/SRF, κ = 0.684 for ERM) were observed. CMT values measured using ACT100 were on average 29.6 μm lower than that of Cirrus (285.8 ± 56.6 vs. 315.4 ± 84.7 μm, <i>p</i> < 0.0001) but showed a strong correlation (R = 0.76, <i>p</i> < 0.0001). <b>Conclusions:</b> ACT100 portable OCT demonstrated high reliability for DME evaluations, comparable to that of stationary systems. 
546 |a EN 
690 |a diabetic macular edema 
690 |a central macular thickness 
690 |a portable OCT 
690 |a intraretinal fluid 
690 |a subretinal fluid 
690 |a epiretinal membrane 
690 |a Medicine 
690 |a R 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceuticals, Vol 17, Iss 10, p 1357 (2024) 
787 0 |n https://www.mdpi.com/1424-8247/17/10/1357 
787 0 |n https://doaj.org/toc/1424-8247 
856 4 1 |u https://doaj.org/article/140489d7176e4c20a9afd70d7ee6db57  |z Connect to this object online.